Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity
Stefania Crippa, … , Giuliana Ferrari, Maria Ester Bernardo
Stefania Crippa, … , Giuliana Ferrari, Maria Ester Bernardo
Published February 25, 2019
Citation Information: J Clin Invest. 2019;129(4):1566-1580. https://doi.org/10.1172/JCI123191.
View: Text | PDF
Clinical Research and Public Health Article has an altmetric score of 8

Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity

  • Text
  • PDF
Abstract

BACKGROUND. The human bone marrow (BM) niche contains a population of mesenchymal stromal cells (MSCs) that provide physical support and regulate hematopoietic stem cell (HSC) homeostasis. β-Thalassemia (BT) is a hereditary disorder characterized by altered hemoglobin beta-chain synthesis amenable to allogeneic HSC transplantation and HSC gene therapy. Iron overload (IO) is a common complication in BT patients affecting several organs. However, data on the BM stromal compartment are scarce. METHODS. MSCs were isolated and characterized from BM aspirates of healthy donors (HDs) and BT patients. The state of IO was assessed and correlated with the presence of primitive MSCs in vitro and in vivo. Hematopoietic supportive capacity of MSCs was evaluated by transwell migration assay and 2D coculture of MSCs with human CD34+ HSCs. In vivo, the ability of MSCs to facilitate HSC engraftment was tested in a xenogenic transplant model, whereas the capacity to sustain human hematopoiesis was evaluated in humanized ossicle models. RESULTS. We report that, despite iron chelation, BT BM contains high levels of iron and ferritin, indicative of iron accumulation in the BM niche. We found a pauperization of the most primitive MSC pool caused by increased ROS production in vitro which impaired MSC stemness properties. We confirmed a reduced frequency of primitive MSCs in vivo in BT patients. We also discovered a weakened antioxidative response and diminished expression of BM niche–associated genes in BT-MSCs. This caused a functional impairment in MSC hematopoietic supportive capacity in vitro and in cotransplantation models. In addition, BT-MSCs failed to form a proper BM niche in humanized ossicle models. CONCLUSION. Our results suggest an impairment in the mesenchymal compartment of BT BM niche and highlight the need for novel strategies to target the niche to reduce IO and oxidative stress before transplantation. FUNDING. This work was supported by the SR-TIGET Core grant from Fondazione Telethon and by Ricerca Corrente.

Authors

Stefania Crippa, Valeria Rossella, Annamaria Aprile, Laura Silvestri, Silvia Rivis, Samantha Scaramuzza, Stefania Pirroni, Maria Antonietta Avanzini, Luca Basso-Ricci, Raisa Jofra Hernandez, Marco Zecca, Sarah Marktel, Fabio Ciceri, Alessandro Aiuti, Giuliana Ferrari, Maria Ester Bernardo

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 Total
Citations: 1 2 2 4 9 9 2 29
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (29)

Title and authors Publication Year
Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities
Bulté D, Barzaghi F, Mesa-Nuñez C, Rigamonti C, Basso-Ricci L, Visconti C, Crippa S, Pettinato E, Gilioli D, Milani R, Quaranta P, Caorsi R, Cafaro A, Cangemi G, Lupia M, Schena F, Grossi A, Di Colo G, Federici S, Insalaco A, De Benedetti F, Marktel S, Di Micco R, Bernardo ME, Scala S, Cicalese MP, Conti F, Miano M, Gattorno M, Dufour C, Aiuti A, Mortellaro A
The Journal of Allergy and Clinical Immunology 2025
Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives
Li Z, Yao X, Zhang J, Yang J, Ni J, Wang Y
Frontiers in Immunology 2024
Long-term lineage commitment in haematopoietic stem cell gene therapy
Calabria A, Spinozzi G, Cesana D, Buscaroli E, Benedicenti F, Pais G, Gazzo F, Scala S, Lidonnici MR, Scaramuzza S, Albertini A, Esposito S, Tucci F, Canarutto D, Omrani M, De Mattia F, Dionisio F, Giannelli S, Marktel S, Fumagalli F, Calbi V, Cenciarelli S, Ferrua F, Gentner B, Caravagna G, Ciceri F, Naldini L, Ferrari G, Aiuti A, Montini E
Nature 2024
Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome
Katzerke C, Schaffrath J, Lützkendorf J, Janssen M, Merbach AK, Nerger K, Binder M, Baum C, Lauer K, Rohde C, Willscher E, Müller-Tidow C, Müller LP
Blood Advances 2023
The influence of iron on bone metabolism disorders.
Zhang H, Yang F, Cao Z, Xu Y, Wang M
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2023
Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients
L Ding, D Han, H Yan, J Zhou, X Zheng, L Zhu, M Xue, J Liu, N Mao, Z Guo, H Ning, H Wang, H Zhu
Bone Marrow Transplantation 2022
The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation
W Fibbe, R Bernardi, P Charbord, D Krause, C Celso, S Méndez-Ferrer, C Mummery, R Oostendorp, M Raaijmakers, G Socié, F Staal, A Bacigalupo
HemaSphere 2022
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease.
Aprile A, Sighinolfi S, Raggi L, Ferrari G
Pharmaceuticals (Basel, Switzerland) 2022
Extracellular Hemoglobin: Modulation of Cellular Functions and Pathophysiological Effects.
Drvenica IT, Stančić AZ, Maslovarić IS, Trivanović DI, Ilić VL
Biomolecules 2022
Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease
A Tang, AN Strat, M Rahman, H Zhang, W Bao, Y Liu, D Shi, X An, D Manwani, P Shi, K Yazdanbakhsh, A Mendelson
Blood 2021
Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome
S Crippa, L Santi, M Berti, GD Ponti, ME Bernardo
Frontiers in Cell and Developmental Biology 2021
Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs
F Longo, A Piolatto, GB Ferrero, A Piga
International journal of molecular sciences 2021
Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy
TO Rosanwo, DE Bauer
Molecular Therapy 2021
Identifying the functions of two biomarkers in human oligodendrocyte progenitor cell development
H Zhou, Y He, Z Wang, Q Wang, C Hu, X Wang, S Lu, K Li, Y Yang, Z Luan
Journal of Translational Medicine 2021
Extracellular Vesicle MicroRNA That Are Involved in β-Thalassemia Complications
C Levin, A Koren, A Rebibo-Sabbah, M Levin, N Koifman, B Brenner, A Aharon
International journal of molecular sciences 2021
The EHA Research Roadmap: Normal Hematopoiesis
T Jaffredo, A Balduini, A Bigas, R Bernardi, D Bonnet, B Canque, P Charbord, A Cumano, R Delwel, C Durand, W Fibbe, L Forrester, L de Franceschi, C Ghevaert, B Gjertsen, B Gottgens, T Graf, O Heidenreich, O Hermine, D Higgs, M Kleanthous, H Klump, V Kouskoff, D Krause, G Lacaud, CL Celso, JH Martens, S Méndez-Ferrer, P Menendez, R Oostendorp, S Philipsen, B Porse, M Raaijmakers, C Robin, H Stunnenberg, K Theilgaard-Mönch, I Touw, W Vainchenker, JL Corrons, L Yvernogeau, JJ Schuringa
HemaSphere 2021
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development National Institutes of Health/Bill & Melinda Gates Foundation Expert Scientific Roundtable Webinar Meeting
P Cannon, A Asokan, A Czechowicz, P Hammond, D Kohn, A Lieber, P Malik, P Marks, M Porteus, E Verhoeyen, D Weissman, I Weissman, H Kiem
Human Gene Therapy 2021
Correlation between Serum Fatty Acid Binding Protein 4 (FABP4) Levels and Cardiac Function in Patients with Thalassemia Major
P Fianza, A Rahmawati, S Afifah, S Praptama, M Ghozali, T Sihite, D Setiabudi, M Syamsunarno, S Fucharoen, R Panigoro, H Zhou
Disease Markers 2021
Update on Clinical Ex Vivo Hematopoietic Stem Cell Gene Therapy for Inherited Monogenic Diseases
F Tucci, S Scaramuzza, A Aiuti, A Mortellaro
Molecular Therapy 2020
Gene therapy using haematopoietic stem and progenitor cells
G Ferrari, AJ Thrasher, A Aiuti
Nature Reviews Genetics 2020
Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche
A Aprile, A Gulino, M Storto, I Villa, S Beretta, I Merelli, A Rubinacci, M Ponzoni, S Marktel, C Tripodo, MR Lidonnici, G Ferrari
Blood 2020
Targeting the bone marrow niche in hemoglobinopathies
N Carlesso
Blood 2020
AMD3100 re-dosing fails to repeatedly mobilize hematopoietic stem cells in the non-human primate and humanized mouse
C Samuelson, S Radtke, M Cui, A Perez, HP Kiem, O Humbert
Experimental Hematology 2020
The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases
Z Kuҫi, C Jordan, S Wehner, J Sörensen, A Jarisch, E Salzmann-Manrique, LM Pfeffermann, T Klingebiel, P Bader, S Kuҫi
Cells 2020
Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders
E Tibaldi, E Federti, A Matte, I Iatcenko, AB Wilson, V Riccardi, MA Pagano, LD Franceschi
Antioxidants 2020
Challenging the Erythropoiesis Paradigm in β-Thalassemia
F Vinchi, SZ Vance
HemaSphere 2020
[Effect of cyclophosphamide on hematopoietic stem cells in mice with iron overload]
Yanjun Xu, Tiantian Yi, Xiaoxiao Xu, Fuyu Pei, Yuelin He, Xuedong Wu
Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2020
Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives
FJ Staal, A Aiuti, M Cavazzana
Frontiers in Pediatrics 2019
Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders
S Crippa, L Santi, R Bosotti, G Porro, ME Bernardo
Journal of Clinical Medicine 2019

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 11 X users
78 readers on Mendeley
See more details